Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity

ConditionStroke
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversiteit Antwerpen

About this trial

This is a randomized parallel group clinical trial which will be conducted in three countries (Spain, Canada and Belgium) comparing Botulinum Toxin type A (BTX-A) and Dry Needling (DN) effectiveness for post-stroke spasticity in participants who had a first stroke in the previous 12 months and have plantar flexor spasticity. Participants will be randomly allocated to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess the effects before, during, and after treatment, and at a 4-week follow-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 18-75 years.

post-stroke spasticity in ankle plantar flexors (Modified Ashworth Scale (MAS) scores of 1-2).

first stroke.

0-12 months evolution.

Disqualifiers

medical conditions interfering with data interpretation.

contraindications for BTX-A or DN treatment.

changes in anti-spasticity medication dosage (if appropriate), either during the trial or within the 3 months prior to participation.

pregnant or breastfeeding.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Botulinum toxin type A

    Drug

    Botulinum toxin type A injections are a treatment technique to treat the spastic muscles in patients with stroke that targets on the neuromuscular endplate zone provoking a chimical disruption of dysfunctional endplates.

  • Dry Needling

    Other intervention

    Dry Needling is a treatment technique to treat the spastic muscles in patients with stroke that targets on the neuromuscular endplate zone provoking a mechanical disruption of dysfunctional endplates.

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: Botulinum Toxin type AActive comparator 1 intervention
Group B: Dry NeedlingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Tonic Stretch Reflex Threshold (TSRT)

TSRT is a novel measures of stretch reflex excitability that provide an indirect indicator of the excitability of α-motoneurons at the level of the spinal cord.

Time frame
Week 1 to 15 and 19.

Secondary outcomes

1

Muscle thickness

It is the estimation of the thickness of the muscle fiber, which is obtained by tracing a line that covers the length of the muscle between the deep and superficial aponeuroses.

Time frame
Week 1 to 15 and 19.
2

Pennation angle

It is the angle between the deep fascia and the line of the fascicle length.

Time frame
Week 1 to 15 and 19.
3

Concurrence matrices

Measures that describe the spatial distribution of gray levels in the texture of an ultrasound image. These matrices, also known as co-occurrence matrices, are used to analyze textural features and patterns in ultrasound images.

Time frame
Week 1 to 15 and 19.
4

Resistance to passive stretching

It will be measured using the Modified Ashworth Scale (MAS). The scale ranges from a minimum value of 0 to a maximum of 4, with 0 indicating no spasticity (no resistance to passive stretching) and 4 representing the most severe spasticity (resistance to passive stretching), characterized by complete rigidity.

Time frame
Week 1 to 15 and 19.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universiteit Antwerpen

Lead sponsor

Instituto de Investigación Sanitaria Aragón

Collaborator

McGill University

Collaborator

Instituto de Salud Carlos III

Collaborator

Fonds de la Recherche en Santé du Québec

Collaborator

Research Foundation Flanders

Collaborator